Daiken Medical Co., Ltd. (TYO:7775)
Japan
· Delayed Price · Currency is JPY 501.00
+1.00 (0.20%)
Mar 12, 2025, 3:30 PM JST
Daiken Medical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | - | 1,436 | 1,025 | 1,151 | 944 | 1,191 | Upgrade
|
| Depreciation & Amortization | - | 214 | 267 | 314 | 256 | 253 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 5 | 28 | 1 | - | 18 | Upgrade
|
| Other Operating Activities | - | -436 | -377 | -219 | -326 | -245 | Upgrade
|
| Change in Accounts Receivable | - | 50 | -99 | 156 | 138 | -132 | Upgrade
|
| Change in Inventory | - | 76 | 29 | -122 | -248 | 326 | Upgrade
|
| Change in Accounts Payable | - | 120 | 113 | -71 | -266 | 67 | Upgrade
|
| Change in Other Net Operating Assets | - | 90 | 3 | -77 | 111 | -42 | Upgrade
|
| Operating Cash Flow | - | 1,555 | 989 | 1,133 | 609 | 1,436 | Upgrade
|
| Operating Cash Flow Growth | - | 57.23% | -12.71% | 86.04% | -57.59% | 63.18% | Upgrade
|
| Capital Expenditures | - | -162 | -198 | -202 | -309 | -163 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -6 | -1 | - | -3 | -6 | Upgrade
|
| Other Investing Activities | - | - | -11 | 6 | 1 | 9 | Upgrade
|
| Investing Cash Flow | - | -168 | -210 | -196 | -311 | -160 | Upgrade
|
| Short-Term Debt Issued | - | 80 | - | - | 200 | - | Upgrade
|
| Long-Term Debt Issued | - | - | 400 | 700 | 800 | 600 | Upgrade
|
| Total Debt Issued | - | 80 | 400 | 700 | 1,000 | 600 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -300 | Upgrade
|
| Long-Term Debt Repaid | - | -659 | -604 | -704 | -908 | -873 | Upgrade
|
| Total Debt Repaid | - | -659 | -604 | -704 | -908 | -1,173 | Upgrade
|
| Net Debt Issued (Repaid) | - | -579 | -204 | -4 | 92 | -573 | Upgrade
|
| Dividends Paid | - | -573 | -565 | -574 | -574 | -546 | Upgrade
|
| Other Financing Activities | - | -11 | -12 | -11 | -10 | -9 | Upgrade
|
| Financing Cash Flow | - | -1,163 | -781 | -589 | -492 | -1,128 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -2 | - | -1 | - | -1 | Upgrade
|
| Net Cash Flow | - | 222 | -2 | 347 | -194 | 147 | Upgrade
|
| Free Cash Flow | - | 1,393 | 791 | 931 | 300 | 1,273 | Upgrade
|
| Free Cash Flow Growth | - | 76.11% | -15.04% | 210.33% | -76.43% | 86.93% | Upgrade
|
| Free Cash Flow Margin | - | 14.29% | 8.66% | 10.90% | 3.82% | 14.94% | Upgrade
|
| Free Cash Flow Per Share | - | 48.49 | 27.53 | 32.41 | 10.44 | 44.31 | Upgrade
|
| Cash Interest Paid | - | 4 | 3 | 3 | 3 | 4 | Upgrade
|
| Cash Income Tax Paid | - | 438 | 379 | 218 | 325 | 288 | Upgrade
|
| Levered Free Cash Flow | - | 1,261 | 776.5 | 802.5 | 72.75 | 1,162 | Upgrade
|
| Unlevered Free Cash Flow | - | 1,264 | 778.38 | 804.38 | 74.63 | 1,165 | Upgrade
|
| Change in Net Working Capital | -84.06 | -316 | -51 | 27 | 445 | -334 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.